2020
DOI: 10.1016/j.plipres.2020.101033
|View full text |Cite
|
Sign up to set email alerts
|

Squalene monooxygenase: a journey to the heart of cholesterol synthesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
47
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
2
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 64 publications
(54 citation statements)
references
References 301 publications
1
47
0
Order By: Relevance
“… 10,41,86 Small increases in plasma membrane cholesterol also promote the rapid and hyper‐sharp proteolytic inactivation of HMGCR, the rate‐determining ER enzyme for sterol biosynthesis 14,42,133,134 . (Figure 1D) The degradation of another key biosynthetic enzyme, squalene monooxygenase, is also stimulated by cholesterol 135,136 . The transcriptional activator, SREBP‐2, drives the expression of diverse sterol‐accretion proteins; for example, HMGCR, squalene monooxygenase and low‐density lipoprotein (LDL) receptors 133 .…”
Section: Cholesterol Homeostasismentioning
confidence: 99%
“… 10,41,86 Small increases in plasma membrane cholesterol also promote the rapid and hyper‐sharp proteolytic inactivation of HMGCR, the rate‐determining ER enzyme for sterol biosynthesis 14,42,133,134 . (Figure 1D) The degradation of another key biosynthetic enzyme, squalene monooxygenase, is also stimulated by cholesterol 135,136 . The transcriptional activator, SREBP‐2, drives the expression of diverse sterol‐accretion proteins; for example, HMGCR, squalene monooxygenase and low‐density lipoprotein (LDL) receptors 133 .…”
Section: Cholesterol Homeostasismentioning
confidence: 99%
“…SM controls flux through the cholesterol synthesis pathway downstream of HMGCR as recently reviewed (68). The regulatory domain of SM, the first 100 amino acids (dubbed N100) is highly responsive to sterols and increased cholesterol or desmosterol levels lead to rapid destruction of the protein, in a feedback loop from cholesterol (33).…”
Section: A Second Control Enzyme -Smmentioning
confidence: 99%
“…Several drugs against SQLE have been evaluated in anti-tumor trials (Cirmena et al, 2018;Liu et al, 2018). Recent study has reported that SQLE can be regulated at transcriptional, translational, and post-translational levels (Chua et al, 2020). Here we report that MYC binds to and activates SQLE promoter.…”
Section: Introductionmentioning
confidence: 99%